Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the acne vulgaris market grown in recent years?

The market for acne vulgaris has seen notable growth in the past few years. It is projected to expand from $7.94 billion in 2024 to $8.47 billion in 2025, with a compound annual growth rate (CAGR) of 6.7%. The remarkable growth during the historical period is due to several factors: an increase in acne cases, customer inclination towards natural components, the proliferation of online retail outlets, funding in research and development, and greater accessibility of over-the-counter products.

How is the acne vulgaris market size expected to evolve during the forecast period?

In the coming years, substantial expansion is anticipated in the acne vulgaris market, with estimates projecting growth to $10.89 billion by the year 2029 at a compound annual growth rate (CAGR) of 6.5%. This projected increase during the forecast period can be tied to several factors including increasing knowledge about skincare, the surge in the population of teenagers, an emphasis on self-care and wellness, a rise in adult acne cases, telemedicine advancements, and ecommerce extension. Notable trends expected throughout this forecast period are advances in technology, introduction of new advanced pharmaceuticals, groundbreaking products, an increase in clinical approval, and innovations in state-of-the-art medical practices.

Get your acne vulgaris market report here!

https://www.thebusinessresearchcompany.com/report/acne-vulgaris-global-market-report

Which key drivers are propelling the acne vulgaris market’s growth?

Anticipated to fuel the acne vulgaris market’s expansion is the surging demand for skincare goods. These products, which are crafted to improve the skin’s wellbeing and aesthetics, span a vast selection, each catering to distinct skin-specific issues, from cleansing to moisturizing and safeguarding. The accentuated demand for these products stems from the sway of social media, escalating skin health issues, inventive product offerings, and the pivot towards preemptive skincare measures, contributing to the growing comprehension of skincare. Treatments for acne vulgaris significantly benefit from skincare products that directly tackle the primary culprits of the condition, including excessive sebum, blocked pores, and bacterial proliferation. Through the incorporation of ingredients like salicylic acid, benzoyl peroxide, and retinoids, these products aid in skin exfoliation, lessening inflammation and fostering cleaner, healthier skin. For instance, in August 2024, as reported by The Cosmetic, Toiletry and Perfumery Association (CTPA), a non-profit based in the UK, the valuation of the European cosmetics market was €96 billion (approximately $105 billion) based on the retail sales price (RSP) in 2023, ranking it among the largest worldwide markets alongside the USA. This marks an increase from the €88 billion (approximately $93 billion) RSP in 2022. Consequently, it’s evident that the enhanced cognizance of skincare plays a substantial role in driving the acne vulgaris market.

What are the market segments in the acne vulgaris industry?

The acne vulgaris market covered in this report is segmented –

1) By Type: Systemic Therapy, Hormonal Therapy, Physical Treatment, Topical Combination Therapy, Other Types

2) By Age Group: 10 To 17 Years, 18 To 44 Years, 45 To 64 Years, 65 Years And Above

3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies

Subsegments:

1) By Systemic Therapy: Oral Antibiotics, Oral Retinoids, Oral Anti-Inflammatory Agents

2) By Hormonal Therapy: Oral Contraceptives, Androgen Receptor Inhibitors

3) By Physical Treatment: Laser Therapy, Light-Based Therapy, Chemical Peels, Microdermabrasion

4) By Topical Combination Therapy: Retinoid And Antibiotic Combinations, Benzoyl Peroxide And Antibiotic Combinations, Retinoid And Benzoyl Peroxide Combinations

5) By Other Types: Herbal And Natural Remedies, Biologic Therapies, Emerging Therapies

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21075&type=smp

Which leading companies are shaping the growth of the acne vulgaris market?

Major companies operating in the acne vulgaris market are Pfizer Inc., Johnson and Johnson, AbbVie Inc., L’Oréal Paris, GlaxoSmithKline Plc., Reckitt Benckiser Group plc, Viatris Inc., Teva Pharmaceuticals, Bausch Healh Companies, Sun Pharmaceutical Industries Ltd., Incyte, Aurobindo Pharma, Lupin Ltd., Torrent Pharmaceuticals, Biocon, Stiefel Laboratories, Mayne Pharma Group Limited, Paratek Pharmaceuticals, Cosmo Pharmaceuticals, AOBiome

What key trends are currently impacting the acne vulgaris market’s development?

Key players in the acne vulgaris market are concentrating their efforts on creating innovative solutions like triple-combination topical treatments, that provides a one-stop, daily-use topical remedy for acne vulgaris. This kind of treatment merges three active constituents, typically designed to address various facets of a condition, delivering increased therapeutic benefits in treating skin disorders such as psoriasis or acne. For example, in October 2023, Bausch Health Companies Inc., a pharmaceutical firm from Canada, received approval from the Food and Drug Administration (FDA) for their product, Cabtreo (clindamycin phosphate, adapalene, and benzoyl peroxide). This topical gel is crafted for managing acne vulgaris in individuals aged 12 and above. It’s an innovative blend of an antibiotic, a retinoid, and an antibacterial agent that targets acne effectively and prohibits future flare-ups. Cabtreo allows for easy usage and shows a positive safety track record for a broad spectrum of patients.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21075

Which geographic areas are influencing the growth of the acne vulgaris market?

North America was the largest region in the acne vulgaris market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acne vulgaris market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Respiratory Disease Vaccine Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/respiratory-disease-vaccine-global-market-report

Pertussis Vaccine Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pertussis-vaccine-global-market-report

Immunomodulator Global Market Report 2025

https://thebusinessresearchcompany.com/report/immunomodulator-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: